Infusion-related febrile reaction after haploidentical stem cell transplantation in children is associated with higher rates of engraftment syndrome and acute graft-versus-host disease

Pediatric Transplantation

Volumn 19, Issue 8, 2015, Pages 918-924

  Chen, Yao ^a   Huang, Xiao Jun ^a   Liu, Kai Yan ^a   Chen, Huan ^a   Chen, Yu Hong ^a   Zhang, Xiao Hui ^a   Wang, Feng Rong ^a   Han, Wei ^a   Wang, Jing Zhi ^a   Wang, Yu ^a   Yan, Chen Hua ^a   Zhang, Yuan Yuan ^a   Sun, Yu Qian ^a   Xu, Lan Ping ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

engraftment syndrome; graft versus host disease; haploidentical stem cell transplantation; infusion related febrile reaction; pediatric

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENGRAFTMENT SYNDROME; FEMALE; GRAFT VERSUS HOST REACTION; HAPLOIDENTICAL HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; HUMAN CELL; INFUSION RELATED FEBRILE REACTION; INFUSION RELATED REACTION; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; ACUTE DISEASE; ADVERSE EFFECTS; CASE CONTROL STUDY; FEVER; FOLLOW UP; GRAFT VS HOST DISEASE; INCIDENCE; MULTIVARIATE ANALYSIS; PARENTERAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PROCEDURES; SYNDROME;

ACUTE DISEASE; ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FEMALE; FEVER; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INCIDENCE; INFUSIONS, PARENTERAL; MALE; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; RISK FACTORS; SYNDROME;

EID: 84955183541     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/petr.12586     Document Type: Article

References (39)

1. Aversa F, Martelli MF, Velardi A,. Haploidentical hematopoietic stem cell transplantation with a megadose T-cell-depleted graft: Harnessing natural and adaptive immunity. Semin Oncol 2012: 39: 643-652.
2. Luznik L, O'Donnell PV, Fuchs EJ,. Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation. Semin Oncol 2012: 39: 683-693.
3. Wang Y, Liu DH, Liu KY, et al., Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: Nine years of experience at a single center. Cancer 2013: 119: 978-985.
4. Liu DH, Xu LP, Liu KY, et al., Long-term outcomes of unmanipulated haploidentical HSCT for paediatric patients with acute leukaemia. Bone Marrow Transplant 2013: 48: 1519-1524.
5. Mo XD, Zhao XY, Liu DH, et al., Umbilical cord blood transplantation and unmanipulated haploidentical hematopoietic SCT for pediatric hematologic malignancies. Bone Marrow Transplant 2014: 49: 1070-1075.
6. Powles RL, Morgenstern GR, Kay HE, et al., Mismatched family donors for bone-marrow transplantation as treatment for acute leukaemia. Lancet 1983: 1: 612-615.
7. Szydlo R, Goldman JM, Klein JP, et al., Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol 1997: 15: 1767-1777.
8. Kanda Y, Chiba S, Hirai H, et al., Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood 2003: 102: 1541-1547.
9. Mehta J, Singhal S, Gee AP, et al., Bone marrow transplantation from partially HLA-mismatched family donors for acute leukemia: Single-center experience of 201 patients. Bone Marrow Transplant 2004: 33: 389-396.
10. Aversa F, Terenzi A, Tabilio A, et al., Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse. J Clin Oncol 2005: 23: 3447-3454.
11. Lu DP, Dong L, Wu T, et al., Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 2006: 107: 3065-3073.
12. Lang P, Greil J, Bader P, et al., Long-term outcome after haploidentical stem cell transplantation in children. Blood Cells Mol Dis 2004: 33: 281-287.
13. Marks DI, Khattry N, Cummins M, et al., Haploidentical stem cell transplantation for children with acute leukaemia. Br J Haematol 2006: 134: 196-201.
14. Liu D, Huang X, Liu K, et al., Haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for treatment of hematological malignancies in children. Biol Blood Marrow Transplant 2008: 14: 469-477.
15. Leung W, Campana D, Yang J, et al., High success rate of hematopoietic cell transplantation regardless of donor source in children with very high-risk leukemia. Blood 2011: 118: 223-230.
16. Wang Y, Chang YJ, Xu LP, et al., Who is the best donor for a related HLA haplotype-mismatched transplant? Blood 2014: 124: 843-850.
17. Chen Y, Xu L, Liu D, et al., Increased risk of severe acute graft-versus-host disease in low body mass index patients undergoing haploidentical allogeneic stem cell transplantation. Zhonghua Nei Ke Za Zhi 2014: 53: 1-4.
18. Colvin GA, Berz D, Ramanathan M, et al., Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: Tumor responses without chimerism. Biol Blood Marrow Transplant 2009: 15: 421-431.
19. Chen Y, Huang XJ, Wang FR, et al., Etiological analysis of fever in the first 24 hours following allogeneic peripheral stem cell transfusion. Zhonghua Nei Ke Za Zhi 2012: 51: 179-183.
20. Chen Y, Huang XJ, Wang Yu, et al., Febrile reaction associated with the infusion of haploidentical peripheral blood stem cells: Incidence, clinical features and risk factors. Transfusion. 2015, doi: 10.1111/trf.13167.
21. Maiolino A, Biasoli I, Lima J, et al., Engraftment syndrome following autologous hematopoietic stem cell transplantation: Definition of diagnostic criteria. Bone Marrow Transplant 2003: 31: 393-397.
22. Glucksberg H, Storb R, Fefer A, et al., Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA matched sibling donors. Transplantation 1974: 18: 295-304.
23. Kishi Y, Kami M, Miyakoshi S, et al., Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation 2005: 80: 34-40.
24. Choi SJ, Lee KH, Lee JH, et al., Peri-engraftment clinical abnormalities following allogeneic hematopoietic cell transplantation: A retrospective review of 216 patients. Bone Marrow Transplant 2003: 32: 809-813.
25. Kim D, Sohn S, Kim J, et al., Clinical impact of hyperacute graft-versus-host disease on results of allogeneic stem cell transplantation. Bone Marrow Transplant 2004: 33: 1025-1030.
26. Gorak E, Geller N, Srinivasan R, et al., Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: Incidence and effects on survival. Biol Blood Marrow Transplant 2005: 11: 542-550.
27. Saliba RM, de Lima M, Giralt S, et al., Hyperacute GVHD: Risk factors, outcomes, and clinical implications. Blood 2007: 109: 2751-2758.
28. Hong KT, Kang HJ, Kim NH, et al., Peri-engraftment syndrome in allogeneic hematopoietic SCT. Bone Marrow Transplant 2013: 48: 523-528.
29. Chang L, Frame D, Braun T, et al., Engraftment syndrome after allogeneic hematopoietic cell transplantation predicts poor outcomes. Biol Blood Marrow Transplant 2014: 20: 1407-1417.
30. Schmid I, Stachel D, Pagel P, et al., Incidence, predisposing factors, and outcome of engraftment syndrome in pediatric allogeneic stem cell transplant recipients. Biol Blood Marrow Transplant 2008: 14: 438-444.
31. Nishio N, Yagasaki H, Takahashi Y, et al., Engraftment syndrome following allogeneic hematopoietic stem cell transplantation in children. Pediatr Transplant 2009: 13: 831-837.
32. Frangoul H, Wang L, Harrell FE Jr, et al., Preengraftment syndrome after unrelated cord blood transplant is a strong predictor of acute and chronic graft-versus-host disease. Biol Blood Marrow Transplant 2009: 15: 1485-1488.
33. Park M, Lee SH, Lee YH, et al., Pre-engraftment syndrome after unrelated cord blood transplantation: A predictor of engraftment and acute graft-versus-host disease. Biol Blood Marrow Transplant 2013: 19: 640-646.
34. Shlomchik WD,. Graft-versus-host disease. Nat Rev Immunol 2007: 7: 340-352.
35. Jadus M, Wepsic HT,. The role of cytokines in graft-versus-host reactions and disease. Bone Marrow Transplant 1992: 10: 1-14.
36. Cahill RA, Spitzer TR, Mazumder A,. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplant 1996: 18: 177-184.
37. Hill GR, Crawford JM, Cooke KR, et al., Total body irradiation and acute graft-versus-host disease: The role of gastrointestinal damage and inflammatory cytokines. Blood 1997: 90: 3204-3213.
38. Krenger W, Hill GR, Ferrara JL,. Cytokine cascades in acute graft-versus-host disease. Transplantation 1997: 64: 553-558.
39. Mapara MY, Leng C, Kim YM, et al., Expression of chemokines in GVHD target organs is influenced by conditioning and genetic factors and amplified by GVHR. Biol Blood Marrow Transplant 2006: 12: 623-634.